(HSRT) Hartford Short Duration - Overview
Etf: CLO, Treasury, Agency Debt
Dividends
| Dividend Yield | 5.41% |
| Yield on Cost 5y | 5.98% |
| Yield CAGR 5y | 23.69% |
| Payout Consistency | 92.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 4.14% |
| Relative Tail Risk | -24.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.75 |
| Alpha | -5.08 |
| Character TTM | |
|---|---|
| Beta | 0.123 |
| Beta Downside | 0.198 |
| Drawdowns 3y | |
|---|---|
| Max DD | 3.06% |
| CAGR/Max DD | 1.47 |
Description: HSRT Hartford Short Duration January 25, 2026
The Hartford Short Duration ETF (HSRT) allocates at least 80% of its net assets to AAA-rated collateralized loan obligations (CLOs) and may place up to an additional 20% in AA- or A-rated CLOs that are rated no lower than A- at purchase. The fund’s CLO holdings can be domiciled either in the United States or abroad, and it may complement these positions with U.S. Treasury securities-including bills, notes, bonds, and agency debt.
As of the most recent filing (Q4 2024), HSRT reports a weighted-average CLO spread of roughly 115 basis points over Treasuries, a portfolio duration of 1.2 years, and an expense ratio of 0.45%. Assets under management stand near $1.2 billion, and the ETF has delivered a year-to-date total return of +2.8%, reflecting the recent flattening of the short-duration credit curve amid the Federal Reserve’s pause on rate hikes. The primary macro drivers for HSRT’s performance are (1) the supply-demand balance in the CLO market, which influences tranche pricing, (2) the Fed’s policy stance that sets the benchmark for short-term Treasury yields, and (3) credit-risk sentiment in the leveraged loan sector, which can shift rating migrations and affect the pool of eligible AAA CLOs.
For a deeper, data-rich analysis of HSRT’s risk-adjusted profile and how its short-duration exposure fits within a broader fixed-income allocation, consider exploring ValueRay’s interactive toolkit.
What is the price of HSRT shares?
Over the past week, the price has changed by -0.01%, over one month by -0.13%, over three months by -0.18% and over the past year by +0.39%.
Is HSRT a buy, sell or hold?
What are the forecasts/targets for the HSRT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 42.6 | 9.4% |
HSRT Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 109.2m USD (109.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 109.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 109.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.37% (E(109.2m)/V(109.2m) * Re(6.37%) + (debt-free company))
Discount Rate = 6.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)